2006
DOI: 10.1073/pnas.0511186103
|View full text |Cite
|
Sign up to set email alerts
|

Activated Src abrogates the Myc requirement for the G 0 /G 1 transition but not for the G 1 /S transition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
34
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(37 citation statements)
references
References 35 publications
3
34
0
Order By: Relevance
“…c-Myc is associated with a wide range of cancers and is an essential regulator of G1/S transition (49,50). While in normal cells inhibition of c-Myc usually results in a G0/G1 cell cycle arrest (51,52), tumour cells exhibit significant heterogeneity with regard to the positioning of cell cycle arrest in response to c-Myc depletion (53). Cannell et al (54) showed that in response to DNA damage c-Myc is translationally repressed by the induction of miR-34c microRNA and that this induction is induced by p38 MAPK/MK2 signalling resulting in S-phase arrest.…”
Section: Discussionmentioning
confidence: 99%
“…c-Myc is associated with a wide range of cancers and is an essential regulator of G1/S transition (49,50). While in normal cells inhibition of c-Myc usually results in a G0/G1 cell cycle arrest (51,52), tumour cells exhibit significant heterogeneity with regard to the positioning of cell cycle arrest in response to c-Myc depletion (53). Cannell et al (54) showed that in response to DNA damage c-Myc is translationally repressed by the induction of miR-34c microRNA and that this induction is induced by p38 MAPK/MK2 signalling resulting in S-phase arrest.…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported that c-SRC is involved in multiple signaling pathways, including RAS/RAF/ERK1/2, PI3K/AKT/ HIF-1a, STAT3/c-MYC/CYCLIND1, B-CATENIN/c-MYC/CYCLIND1, FAK/p130CAS/MMP9 and RAC/NADPH, which induce the growth, survival and migration of various types of cancer cells. [39][40][41] The ability to target c-SRC transcripts signifies that miR-205 might be a potential regulator of the FAK/ERK1/2 pathways in PCa cells. Western blot analysis showed that the expression levels of the members of the FAK/ ERK1/2 pathway were reduced through targeting with c-SRC after miR-205 overexpression (Figure 4b).…”
Section: Mir-205 Suppresses Tumor Growth In Vivomentioning
confidence: 99%
“…Cell line-specific effects of c-Myc depletion A large body of literature suggests that inhibition of c-Myc in primary cells or non-transformed cell lines generally leads to a strong proliferative arrest in the G 0 / G 1 or G 1 /S phases of the cell cycle (Prochownik et al, 1988;Mateyak et al, 1997;de Alboran et al, 2001;Prathapam et al, 2006). In order to determine whether this is also the case for tumor cells, we used propidium iodide (PI) staining and flow cytometry to evaluate the cell cycle parameters of the above-described cells 4-5 days after infection ( Figure S3B), we conclude that c-Myc depletion blocks cell cycle progression in these cells equally in all phases.…”
Section: Myc-dependent Cell Cycle Regulation In Tumor Cells H Wang Et Almentioning
confidence: 99%
“…In normal cells, inhibition of c-Myc invariably results in a G 0 /G 1 cell cycle arrest (Prochownik et al, 1988;Mateyak et al, 1997;de Alboran et al, 2001;Prathapam et al, 2006). The type of cell cycle arrest caused by c-Myc depletion in tumor cells has not been adequately studied.…”
Section: Introductionmentioning
confidence: 99%